KARLIN DANIEL (Chief Medical Officer) sold 1.8% of their position (7.85K shares) of DEFINIUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $53.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/26/2025ACC: 0000950170-25-090429
Officer· Chief Medical Officer
Since Jan 2022
-7.85K
Net shares
Net seller
$53.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.85K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−7.85K
Price / share
$6.80
Trade value
$53.37K
% of position
1.8%
6/25/2025
446.18K→438.33K
Total
Net shares
−7.85K
Net value
-$53.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 6/25/2025 | S · Sale | −7.85K | $6.80 | $53.37K | 1.8% | 446.18K | 438.33K |
| Total | −7.85K | -$53.37K | ||||||
Derivative Transactions0
No derivative transactions reported